Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 1.489% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: CCC(=O)Nc1nnc(CSCc2ccc(F)cc2)s1
b: CCCCCC1CC1C(=O)N/N=C/c1ccc(N(C)C)cc1
c: COc1ccc(C(C(=O)NC2CCCC2)N(C(=O)c2ccoc2C)c2cc(C)cc(C)c2)cc1
d: O=C(c1ccc(F)cc1)C1CCN(C(=O)c2ccccc2F)CC1
Answer: a. CCC(=O)Nc1nnc(CSCc2ccc(F)cc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1nnc(CSCc2ccc(F)cc2)s1
CCC(=O)Nc1nnc(CSCc2ccc(F)cc2)s1
N-[5-[(4-fluorophenyl)methylsulfanylmethyl]-1,3,4-thiadiazol-2-yl]propanamide